Clik here to view.
Takeda Announces the Publication of Its Annual Report on Form 20-F for FY2020
OSAKA, Japan Takeda Pharmaceutical Company Limited (“Takeda”) (TSE:4502/NYSE:TAK) today announced that it has filed its Annual Report on Form 20-F for the fiscal year ended March 31, 2021 (the...
View ArticleClik here to view.
Solasia Announces Submission of New Drug Application for Anti-cancer Drug...
TOKYO Solasia Pharma K.K. (TSE: 4597, Headquarters: Tokyo, Japan, President & CEO: Yoshihiro Arai, hereinafter “Solasia”) today announced submission of a New Drug Application (NDA) for its new...
View ArticleClik here to view.
ソレイジア・ファーマ：開発品SP-02 製造販売承認申請（日本）のお知らせ
東京 （ビジネスワイヤ） — 当社は、新規抗がん剤ダリナパルシン（一般名、開発コード：SP-02）につき、再発又は難治性の末梢性T細胞リンパ腫（Peripheral T-Cell...
View ArticleClik here to view.
武田发布2020财年Form 20-F年度报告
日本大阪 (美国商业资讯)–武田药品工业株式会社(Takeda Pharmaceutical Company Limited, TSE:4502/NYSE:TAK)（“武田”）今天宣布，公司已向美国证券交易委员会(SEC)提交了截至2021年3月31日财年的Form 20-F年度报告（“年度报告”）。武田于2021年6月29日向SEC提交了年度报告，该报告可在武田网站...
View ArticleClik here to view.
QIAGEN Forms Strategic Alliance With Sysmex Corporation for Global Cancer...
HILDEN, Germany & GERMANTOWN, Md. & KOBE, Japan QIAGEN (NYSE:QGEN; Frankfurt Prime Standard:QIA) today announced a global strategic alliance with Japan’s Sysmex Corporation (Tokyo Stock...
View ArticleClik here to view.
Solasia宣布在日本提交抗癌药物DARINAPARSIN用于外周T细胞淋巴瘤的新药申请
东京 (美国商业资讯)–Solasia Pharma K.K.（TSE:4597，总部：日本东京，总裁兼首席执行官：Yoshihiro...
View ArticleClik here to view.
Clik here to view.
PHC株式会社：最先端のゲノム医療研究への貢献を目指した、次世代シーケンサー「DNBSEQ™シリーズ」を発売
東京 （ビジネスワイヤ） — PHC株式会社（本社：東京都港区、代表取締役社長：森本 恭史、以下「PHC」）は、このたび、MGI Tech Co., Ltd.（本社：中華人民共和国深セン市、代表取締役社長：牟...
View ArticleClik here to view.
Alvotech Initiates Clinical Studies for AVT04, a Proposed Biosimilar to...
REYKJAVIK, Iceland Alvotech, the Iceland-based biosimilar company, today announced that the first patient has been dosed in the comparative, confirmatory efficacy and safety clinical study...
View ArticleClik here to view.
Biocept Receives South Korean Patent for Primer-Switch Platform Used to...
SAN DIEGO Biocept, Inc. (NASDAQ: BIOC), a leading provider of molecular diagnostic assays and services, has been awarded a South Korean Patent for its Primer-Switch technology, which detects rare...
View ArticleClik here to view.
EpimAb Biotherapeutics Provides Clinical Update for EMB-02 and EMB-06
SHANGHAI & SUZHOU, China EpimAb Biotherapeutics, a clinical stage biotech company specializing in bispecific antibodies, today announced dose administration for the first patient in a Phase 1/2...
View ArticleClik here to view.
Alvotech启动Stelara® (Ustekinumab)拟议生物仿制药AVT04的临床研究
冰岛雷克雅未克 (美国商业资讯)–总部位于冰岛的生物仿制药公司Alvotech今天宣布，AVT04有效性和安全性对照验证研究(AVT04-GL-301)的首例患者已经给药，AVT04是Alvotech参考产品Stelara®的拟议生物仿制药。该研究旨在从安全性、有效性和免疫原性方面展示AVT04和Stelara®治疗中至重度慢性斑块状银屑病患者的等效性。...
View ArticleClik here to view.
Clik here to view.
U.S. FDA Grants Regular Approval and Expands Indication for PADCEV®...
BOTHELL, Wash. & TOKYO Seagen Inc. (Nasdaq:SGEN) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”) today announced the U.S. Food and Drug Administration...
View ArticleClik here to view.
AIDOT Accelerates Its Export Drive for AI Remote Readout System to Developing...
SEOUL, South Korea AIDOT Inc., a medical ICT company, announced that it has strengthened exporting Cerviray AI, a cervical cancer remote readout system, to enhance women’s health in developing...
View ArticleClik here to view.
NEC’s Artificial Intelligence (AI) Supports Doctors to Determine If...
TOKYO NEC Corporation (NEC; TOKYO: 6701) announced today the development of an AI technology for supporting doctors in determining if colorectal lesions are neoplastic or non-neoplastic. NEC...
View ArticleClik here to view.
Anticancer Bioscience Appoints Leader in Oncology Drug Development, Dr. Hong...
CHENGDU, China Anticancer Bioscience (ACB), pioneers in synthetic lethal approaches to precision oncology, announced today appointment of Dr. Hong Liu as VP of Clinical Development. A...
View ArticleClik here to view.
NEC的人工智能(AI)帮助医生确定结直肠病灶有无癌变
东京 (美国商业资讯)–NEC Corporation (NEC; TOKYO: 6701)今天宣布一项人工智能技术取得进展，该技术可帮助医生确定结直肠病灶是否属于癌变。NEC开发了一项名为“Cx20”的新技术，同时寻求早期检出结直肠病灶的辅助手段。Cx20已达到欧洲安全、健康和环保标准CE标志的要求，并将整合到医疗器械AI诊断支持软件“WISE VISION®...
View ArticleClik here to view.
Bio-Thera Solutions Announces the First Patient Dosed in Phase III Clinical...
GUANGZHOU, China Bio-Thera Solutions, Ltd. (688177.SH), a commercial-stage pharmaceutical company, today announced that the first patient has been dosed in a Phase III clinical study for BAT2206, a...
View ArticleClik here to view.
CANbridge Pharmaceuticals CAN106 Investigational New Drug Application...
BEIJING & CAMBRIDGE, Mass. CANbridge Pharmaceuticals Inc., a leading China-based global rare disease-focused biopharmaceutical company committed to the research, development and...
View Article